0

AGN 193109

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP171746217
CAS171746-21-7
Structure
MDL NumberMFCD00943817
Molecular Weight392.49
Description≥98% (HPLC)
SolubilityDMSO: 2 mg/mL, clear (warmed)
Assay≥98% (HPLC)
Colorwhite to beige
Formpowder
Size5MG, 25MG
Storage Conditions−20°C
1

All-trans Retinoic Acid Enhances the Long-Term Repopulating Activity of Cultured Hematopoietic Stem Cells

L E Purton, I D Bernstein, S J Collins

Blood. 2000 Jan 15;95(2):470-7.

PMID: 10627451

1

Cell Type and Gene-Specific Activity of the Retinoid Inverse Agonist AGN 193109: Divergent Effects From Agonist at Retinoic Acid Receptor Gamma in Human Keratinocytes

S M Thacher, S Nagpal, E S Klein, T Arefieg, G Krasinski, D DiSepio, C Agarwal, A Johnson, R L Eckert, R A Chandraratna

Cell Growth Differ. 1999 Apr;10(4):255-62.

PMID: 10319995

1

High Affinity Retinoic Acid Receptor Antagonists: Analogs of AGN 193109

A T Johnson, L Wang, S J Gillett, R A Chandraratna

Bioorg Med Chem Lett. 1999 Feb 22;9(4):573-6.

PMID: 10098666

1

Specific Antagonist of Retinoid Toxicity in Mice

A M Standeven, A T Johnson, M Escobar, R A Chandraratna

Toxicol Appl Pharmacol. 1996 May;138(1):169-75.

PMID: 8658506

1

The Synthetic Retinoid AGN 193109 but Not Retinoic Acid Elevates CYP1A1 Levels in Mouse Embryos and Hepa-1c1c7 Cells

D R Soprano, C J Gambone, S N Sheikh, J L Gabriel, R A Chandraratna, K J Soprano, D M Kochhar

Toxicol Appl Pharmacol. 2001 Jul 15;174(2):153-9.

PMID: 11446831

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode